Wednesday, March 03, 2021 1:22:41 PM
Recent MNMD News
- MindMed Announces New Employee Inducement Grants • Business Wire • 09/09/2024 08:01:00 PM
- MindMed to Participate in September Investor Conferences • Business Wire • 09/04/2024 11:00:00 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/22/2024 08:30:13 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/21/2024 01:14:04 AM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/13/2024 11:25:20 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/13/2024 11:15:08 AM
- MindMed Reports Second Quarter 2024 Financial Results and Business Updates • Business Wire • 08/13/2024 11:00:00 AM
- U.S. Futures Climb Before Inflation Data; Oil Slips on OPEC Demand Cut • IH Market News • 08/13/2024 09:45:01 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/12/2024 12:38:22 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 08/12/2024 10:11:49 AM
- Mind Medicine (MindMed) Inc. Announces Pricing of Public Offering • Business Wire • 08/09/2024 12:44:00 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 08/09/2024 10:04:54 AM
- Mind Medicine (MindMed) Inc. Announces Proposed Public Offering • Business Wire • 08/09/2024 10:00:00 AM
- MindMed to Present at Canaccord Genuity’s 44th Annual Growth Conference • Business Wire • 08/06/2024 08:01:00 PM
- MindMed to Host Conference Call and Webcast to Discuss Second Quarter 2024 Financial Results and Provide Business Update • Business Wire • 08/06/2024 11:00:00 AM
- MindMed Appoints Stephanie Fagan as Chief Corporate Affairs Officer • Business Wire • 07/29/2024 11:00:00 AM
- MindMed Announces Issuance of New Patent for MM120 Orally Disintegrating Tablet (ODT) • Business Wire • 07/17/2024 11:00:00 AM
- MindMed to be Included in Russell 2000® and Russell 3000® Indexes • Business Wire • 06/28/2024 11:00:00 AM
- MindMed to Present at the H.C. Wainwright 5th Annual Neuro Perspectives Virtual Conference • Business Wire • 06/21/2024 11:00:00 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/20/2024 12:00:10 PM
- MindMed Announces Constructive End-of-Phase 2 Meeting with U.S. FDA for MM120 in Generalized Anxiety Disorder (GAD) • Business Wire • 06/20/2024 11:00:00 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/11/2024 08:30:10 PM
- MindMed to Participate in June Conferences • Business Wire • 05/28/2024 11:00:00 AM
- MindMed to Participate at May Investor Conferences • Business Wire • 05/09/2024 08:01:00 PM
- New Studies Presented at the International Society for Health Economics and Outcomes Research Meeting (ISPOR 24) Show Growing Burden and Impact of Generalized Anxiety Disorder (GAD) in the US • Business Wire • 05/09/2024 12:00:00 PM
FEATURED Cannabix Technologies and Omega Laboratories Inc. Advance Marijuana Breathalyzer Technology - Dr. Bruce Goldberger to Present at Society of Forensic Toxicologists Conference • Sep 24, 2024 8:50 AM
FEATURED Integrated Ventures, Inc Announces Strategic Partnership For GLP-1 (Semaglutide) Procurement Through MedWell USA, LLC. • Sep 24, 2024 8:45 AM
Avant Technologies Accelerates Creation of AI-Powered Platform to Revolutionize Patient Care • AVAI • Sep 24, 2024 8:00 AM
VHAI - Vocodia Partners with Leading Political Super PACs to Revolutionize Fundraising Efforts • VHAI • Sep 19, 2024 11:48 AM
Dear Cashmere Group Holding Co. AKA Swifty Global Signs Binding Letter of Intent to be Acquired by Signing Day Sports • DRCR • Sep 19, 2024 10:26 AM
HealthLynked Launches Virtual Urgent Care Through Partnership with Lyric Health. • HLYK • Sep 19, 2024 8:00 AM